Vancomycin Hydrochloride

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers, 20 USDMF, 16 CEP/COS, 8 JDMF, 1 EU WC, 13 KDMF, 21 NDC API, 21 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

314 Dossiers, 140 FDA Orange Book, 72 Europe, 25 Canada, 10 Australia, 13 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL, CAPSULE;ORAL - EQ 125MG BASE, CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 14 BASF, 6 Roquette, 6 Actylis, 4 ACG Worldwide, 3 Lonza Capsugel, 2 Seqens, 2 Gangwal Chemicals, 2 Finar, 2 Nomisma Healthcare, 2 Nanjing Well Pharmaceutical, 1 Qualicaps, 1 Seppic

EXCIPIENTS BY APPLICATIONS

11 Topical, 8 Empty Capsules, 8 Parenteral, 7 Coating Systems & Additives, 6 Film Formers & Plasticizers, 5 Solubilizers, 5 Thickeners and Stabilizers, 5 Controlled & Modified Release, 3 Granulation, 3 Fillers, Diluents & Binders, 3 Taste Masking, 2 Lubricants & Glidants, 1 Direct Compression

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions, 65 Finished Drug Prices

MARKET PLACE

36 APIs, 20 DOSSIERS // FDF

PATENTS

60 US Patents, 4 US Exclusivities

ANALYTICAL SOLUTION(s)

1 Analytical Solutions, 1 EDQM Standards, 2 USP Standards, 4 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 92 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Vancomycin Hydrochloride

Vancomycin Hydrochloride

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

43 Suppliers

20 USDMF

16 CEP/COS

8 JDMF

1 EU WC

13 KDMF

21 NDC API

21 Listed Suppliers

DEVELOPMENTS

13 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

314 Dossiers

140 FDA Orange Book

72 Europe

25 Canada

10 Australia

13 South Africa

54 Listed Dossiers

DRUG PRODUCT COMPOSITION

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL

POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL

CAPSULE;ORAL - EQ 125MG BASE

CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

14 BASF

6 Roquette

6 Actylis

4 ACG Worldwide

3 Lonza Capsugel

2 Seqens

2 Gangwal Chemicals

2 Finar

2 Nomisma Healthcare

2 Nanjing Well Pharmaceutical

1 Qualicaps

1 Seppic

EXCIPIENTS BY APPLICATIONS

11 Topical

8 Empty Capsules

8 Parenteral

7 Coating Systems & Additives

6 Film Formers & Plasticizers

5 Solubilizers

5 Thickeners and Stabilizers

5 Controlled & Modified Release

3 Granulation

3 Fillers, Diluents & Binders

3 Taste Masking

2 Lubricants & Glidants

1 Direct Compression

GLOBAL SALES INFORMATION

22 US Medicaid Prescriptions

65 Finished Drug Prices

MARKET PLACE

36 APIs

20 DOSSIERS // FDF

PATENTS

60 US Patents

4 US Exclusivities

ANALYTICAL SOLUTION(s)

1 Analytical Solutions

1 EDQM Standards

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons